373 related articles for article (PubMed ID: 17207365)
1. [Evaluation of efficacy and safety of using molecular adsorbent recirculating system in the treatment of patients with chronic liver failure].
Lu XB; Xiao L; Zhang YX; Liu H; Yan GX; Xu L; Sun LH
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jan; 19(1):44-6. PubMed ID: 17207365
[TBL] [Abstract][Full Text] [Related]
2. [Clinical research of patients with acute or chronic hepatic failure treated with molecular adsorbent recirculating system].
Zhou X; Wang X; Yang Y; Zhao L; Miao J; Ding J; Fan D
Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):213-5. PubMed ID: 12113683
[TBL] [Abstract][Full Text] [Related]
3. [A pilot study of using pure albumin as a dialysate in the treatment of liver failure].
Liu Q; Peng L; Du Y; Li M; Jia N; Zou HQ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Oct; 17(10):599-602. PubMed ID: 16259917
[TBL] [Abstract][Full Text] [Related]
4. Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience.
Chiu A; Chan LM; Fan ST
Liver Int; 2006 Aug; 26(6):695-702. PubMed ID: 16842326
[TBL] [Abstract][Full Text] [Related]
5. Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study.
Faybik P; Bacher A; Kozek-Langenecker SA; Steltzer H; Krenn CG; Unger S; Hetz H
Crit Care; 2006 Feb; 10(1):R24. PubMed ID: 16469128
[TBL] [Abstract][Full Text] [Related]
6. Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure.
Di Campli C; Santoro MC; Gaspari R; Merra G; Zileri Dal Verme L; Zocco MA; Piscaglia AC; Di Gioacchino G; Novi M; Santoliquido A; Flore R; Tondi P; Proietti R; Gasbarrini G; Pola P; Gasbarrini A
Transplant Proc; 2005; 37(6):2547-50. PubMed ID: 16182739
[TBL] [Abstract][Full Text] [Related]
7. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis.
Khuroo MS; Khuroo MS; Farahat KL
Liver Transpl; 2004 Sep; 10(9):1099-106. PubMed ID: 15349999
[TBL] [Abstract][Full Text] [Related]
8. Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs.
Gaspari R; Cavaliere F; Sollazzi L; Perilli V; Melchionda I; Agnes S; Gasbarrini A; Avolio AW
Transplant Proc; 2009; 41(1):253-8. PubMed ID: 19249528
[TBL] [Abstract][Full Text] [Related]
9. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices.
Evenepoel P; Laleman W; Wilmer A; Claes K; Kuypers D; Bammens B; Nevens F; Vanrenterghem Y
Artif Organs; 2006 Apr; 30(4):276-84. PubMed ID: 16643386
[TBL] [Abstract][Full Text] [Related]
10. Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation -- a pilot study.
Choi JY; Bae SH; Yoon SK; Cho SH; Yang JM; Han JY; Ahn BM; Chung KW; Sun HS; Kim DG
Liver Int; 2005 Aug; 25(4):740-5. PubMed ID: 15998424
[TBL] [Abstract][Full Text] [Related]
11. Molecular adsorbent recycling system in treating patients with acute liver failure: a bridge to liver transplantation.
Ding YT; Xu QX; Qiu YD; Yang YJ
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):508-10. PubMed ID: 15567734
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute-on-chronic liver failure.
Schmidt LE; Sørensen VR; Svendsen LB; Hansen BA; Larsen FS
Liver Transpl; 2001 Dec; 7(12):1034-9. PubMed ID: 11753905
[TBL] [Abstract][Full Text] [Related]
13. One hundred sixteen cases of acute liver failure treated with MARS.
Novelli G; Rossi M; Pretagostini M; Pugliese F; Ruberto F; Novelli L; Nudo F; Bussotti A; Corradini S; Martelli S; Berloco PB
Transplant Proc; 2005; 37(6):2557-9. PubMed ID: 16182742
[TBL] [Abstract][Full Text] [Related]
14. [Impact of heparin on coagulation index during the therapy of molecular adsorbent recirculating system in patients with liver failure].
Yuan S; Zhou Y; Tan D; Li D; Zhou T; Xie Q; Fan J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 36(9):830-5. PubMed ID: 21946197
[TBL] [Abstract][Full Text] [Related]
15. Pro-inflammatory interleukin-18 and Caspase-1 serum levels in liver failure are unaffected by MARS treatment.
Roth GA; Faybik P; Hetz H; Hacker S; Ankersmit HJ; Bacher A; Thalhammer T; Krenn CG
Dig Liver Dis; 2009 Jun; 41(6):417-23. PubMed ID: 19019743
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic improvement as an additional parameter to evaluate the safety and tolerability of the molecular adsorbent recirculating system in liver failure patients.
Pugliese F; Novelli G; Poli L; Levi Sandri GB; Di Folco G; Ferretti S; Morabito V; Ruberto F; Berloco PB
Transplant Proc; 2008; 40(6):1925-8. PubMed ID: 18675091
[TBL] [Abstract][Full Text] [Related]
17. MARS dialysis in decompensated alcoholic liver disease: a single-center experience.
Wolff B; Machill K; Schumacher D; Schulzki I
Liver Transpl; 2007 Aug; 13(8):1189-92. PubMed ID: 17663393
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with molecular adsorbent recirculating system (MARS) in patients with drug-induced liver failure.
Zhou XM; Miao JY; Yang Y; Zhao L; Wang X; Xu L; Ding J; Wu KC; Fan DM; Wang MM
Artif Organs; 2004 May; 28(5):483-6. PubMed ID: 15113343
[TBL] [Abstract][Full Text] [Related]
19. [Application of molecular adsorbents recirculating system in the treatment for liver failure of hepatitis B].
Chen SB; Zhang LL; Shi YF; Yang XL; Wang ZH
Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):131-3. PubMed ID: 15059292
[TBL] [Abstract][Full Text] [Related]
20. Pediatric acute liver failure with molecular adsorbent recirculating system treatment.
Novelli G; Rossi M; Morabito V; Pugliese F; Ruberto F; Perrella SM; Novelli S; Spoletini G; Ferretti G; Mennini G; Berloco PB
Transplant Proc; 2008; 40(6):1921-4. PubMed ID: 18675090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
